Dr. Mina Izadjoo

Dr. Mina Izadjoo has worked in a variety of roles since 1997. Dr. Mina began their career at the Armed Forces Institute of Pathology, where they served as Division Chief of Wound Biology and Translational Research from 1997 to 2011. Dr. Mina then moved to the Henry M Jackson Foundation for Advancement of Military Medicine, where they were the Director of the Diagnostics and Translational Research Center from 2011 to 2014. In 2014, they joined Trideum Biosciences as the Vice President and Chief Science Officer (CSO). In 2016, they became President Emeritus at the Washington Academy of Sciences. Most recently, they have been the President and Chief Science Officer at Integrated Pharma Services since 2018.

Dr. Mina Izadjoo obtained a Doctor of Philosophy (Ph.D.) in Microbiology and Immunology from Louisiana State University between 1987 and 1992. Following this, they undertook Poctodoctoral Training in Immunogenomics at Texas A&M University between 1992 and 1995. Dr. Mina then completed a Postdoctoral Fellowship in Molecular Biology at the National Institutes of Health between 1995 and 1997.